Equity Overview
Price & Market Data
Price: $2.29
Daily Change: +$0.03 / 1.31%
Range: $2.23 - $2.33
Market Cap: $15,257,949
Volume: 5,147
Performance Metrics
1 Week: 5.01%
1 Month: 3.15%
3 Months: -0.82%
6 Months: -18.21%
1 Year: -18.51%
YTD: -6.91%
Company Details
Employees: 28
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. It develops ME-344, an intravenous small molecule inhibitor mitochondrial oxidative phosphorylation to treat human epidermal growth factor receptor 2 negative breast cancer, colorectal cancer, and solid tumors. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California.